SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
Dividends
SpyGlass Pharma, Inc. Common Stock dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.15%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does SpyGlass Pharma, Inc. Common Stock compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Alcon Inc. NYSE:ALC | $35.61B | 0.55% | $0.36 | 19.70% | 2.48% |
Glaukos Corporation NYSE:GKOS | $14.55B | 0.00% | $0.00 | 0.00% | 0.02% |
Bausch + Lomb Corporation NYSE:BLCO | $7.54B | 0.00% | $0.00 | 0.00% | 0.36% |
Ocular Therapeutix, Inc. NASDAQ:OCUL | $1.37B | 0.00% | $0.00 | 0.00% | 0.00% |
STAAR Surgical Company NASDAQ:STAA | $1.32B | 0.00% | $0.00 | 0.00% | 0.67% |
Sight Sciences, Inc. NASDAQ:SGHT | $601.92M | 0.00% | $0.00 | 0.00% | 0.00% |
Oculis Holding AG NASDAQ:OCS | $471.63M | 0.00% | $0.00 | 0.00% | 0.00% |
RxSight, Inc. NASDAQ:RXST | $223.06M | 0.00% | $0.00 | 0.00% | 0.00% |
EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT | $25.66M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about SGP's dividend, answered from reported figures.
Does SGP stock pay dividends?
SpyGlass Pharma, Inc. Common Stock (SGP) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is SGP's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.